The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer

被引:0
|
作者
Francisco C. Muñoz-Casares
Sebastián Rufián
María J. Rubio
Carlos J. Díaz
Rafael Díaz
Ángela Casado
Álvaro Arjona
María C. Muñoz-Villanueva
Jordi Muntané
机构
[1] Reina Sofía University Hospital,Department of General Surgery, Surgical Oncology Unit
[2] Reina Sofía University Hospital,Department of Oncology
[3] Reina Sofía University Hospital,Research Unit
来源
关键词
Hyperthermia; Intraperitoneal chemotherapy; Peritonectomy; Ovarian cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:753 / 759
页数:6
相关论文
共 50 条
  • [1] The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer
    Munoz-Casares, Francisco C.
    Rufian, Sebastian
    Rubio, Maria J.
    Diaz, Carlos J.
    Diaz, Rafael
    Casado, Angela
    Arjona, Alvaro
    Munoz-Villanueva, Maria C.
    Muntane, Jordi
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (11): : 753 - 759
  • [2] Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: An argued role
    Di Giorgio, Angelo
    Cardi, Maurizio
    Sammartino, Paolo
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 117 (01) : 146 - 147
  • [3] Hyperthermic intraperitoneal chemotherapy (HIPEC). Mechanisms of action and the role of HIPEC in the treatment of peritoneal carcinomatosis
    Bartos, Adrian
    Bartos, Dana
    Herdean, Andrei
    Szabo, Bianca
    Militaru, Claudia
    Raluca, Stoian
    Calin, Mitre
    Iancu, Cornel
    Breazu, Caius
    [J]. ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (06) : 513 - 527
  • [4] Safety and Potential Benefit of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Carcinomatosis From Primary or Recurrent Ovarian Cancer
    Roviello, Franco
    Pinto, Enrico
    Corso, Giovanni
    Pedrazzani, Corrado
    Caruso, Stefano
    Filippeschi, Marco
    Petrioli, Roberto
    Marsili, Stefania
    Mazzei, Maria Antonietta
    Marrelli, Daniele
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (06) : 663 - 670
  • [5] The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis
    Ozcan, Pirilti
    Duzgun, Ozgul
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [6] Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis
    Detroz, B
    Laurent, S
    Honoré, P
    Blaffart, E
    Limet, R
    Meurisse, M
    [J]. ACTA CHIRURGICA BELGICA, 2004, 104 (04) : 377 - 383
  • [7] There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
    Schwameis, Richard
    Chiva, Luis
    Harter, Philipp
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 578 - 578
  • [8] The Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
    Helm, C. William
    [J]. ONCOLOGIST, 2009, 14 (07): : 683 - 694
  • [9] Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer
    Di Giorgio, Angelo
    Naticchioni, Enzo
    Biacchi, Daniele
    Sibio, Simone
    Accarpio, Fabio
    Rocco, Monica
    Tarquini, Sergio
    Di Seri, Marisa
    Ciardi, Antonio
    Montruccoli, Daniele
    Sammartino, Paolo
    [J]. CANCER, 2008, 113 (02) : 315 - 325
  • [10] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Vassos, Nikolaos
    Foertsch, Thomas
    Aladashvili, Archil
    Hohenberger, Werner
    Croner, Roland S.
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14